Lymphatic vasculature in ovarian cancer
Ovarian cancer (OVCA) is the second most common gynecological cancer and one of the
leading causes of cancer related mortality among women. Recent studies suggest that …
leading causes of cancer related mortality among women. Recent studies suggest that …
Therapeutic strategies focused on cancer-associated hypercoagulation for ovarian clear cell carcinoma
R Tamura, K Yoshihara, T Enomoto - Cancers, 2022 - mdpi.com
Simple Summary Ovarian clear cell carcinoma (OCCC) has a poor prognosis in advanced
cases and displays resistance to standard treatments for epithelial ovarian cancer. OCCC …
cases and displays resistance to standard treatments for epithelial ovarian cancer. OCCC …
[HTML][HTML] Kaempferia parviflora extract inhibits TNF-α-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-κB signaling
P Thaklaewphan, J Ruttanapattanakul… - Biomedicine & …, 2021 - Elsevier
Ovarian clear cell carcinoma (OCCC) is an uncommon subtype of epithelial cell ovarian
cancers (EOCs) that has poor response to conventional platinum-based therapy. Therefore …
cancers (EOCs) that has poor response to conventional platinum-based therapy. Therefore …
Exosomal MicroRNA as biomarkers for diagnosing or monitoring the progression of ovarian clear cell carcinoma: a pilot study
K Horie, N Nanashima, Y Yokoyama, H Yoshioka… - Molecules, 2022 - mdpi.com
Ovarian cancer is the most common cause of gynecological malignancy-related mortality
since early-stage disease is difficult to diagnose. Advanced clear cell carcinoma of the ovary …
since early-stage disease is difficult to diagnose. Advanced clear cell carcinoma of the ovary …
Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology
Simple Summary Ovarian cancer is still a high-risk, metastatic disease, often diagnosed at a
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma
M Nakagawa, T Matsumoto, A Yokoi… - Molecular …, 2023 - Wiley Online Library
Ezrin‐radixin‐moesin‐binding phosphoprotein 50 (EBP50) is a scaffold protein that is
required for epithelial polarity. Knockout (KO) of membranous EBP50 (Me‐EBP50) in …
required for epithelial polarity. Knockout (KO) of membranous EBP50 (Me‐EBP50) in …
[HTML][HTML] Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study
Background/purpose To compare the clinical outcomes of Taiwanese patients with ovarian
clear cell carcinomas (CCCs) and serous carcinomas (SCs). Methods We retrieved the …
clear cell carcinomas (CCCs) and serous carcinomas (SCs). Methods We retrieved the …
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
M Yoshihara, H Kajiyama, S Tamauchi… - Journal of …, 2019 - synapse.koreamed.org
Objective The aim of this study was to investigate the clinical characteristics of young
patients with stage I clear-cell carcinoma (CCC) and evaluate the prognostic factors and …
patients with stage I clear-cell carcinoma (CCC) and evaluate the prognostic factors and …
The role of long non-coding rnf144a-AS1 in cancer progression
W Wu, X Li, X Li, J Zhao, Y Gui, Y Luo, H Wang… - Cell Biochemistry and …, 2024 - Springer
RNAs transcribing more than 200 nucleotides without encoding proteins are termed long
non-coding RNAs (LncRNAs). LncRNAs can be used as decoy molecules, signal molecules …
non-coding RNAs (LncRNAs). LncRNAs can be used as decoy molecules, signal molecules …
[HTML][HTML] Ovarian cancer: molecular classification and targeted therapy
F Ravindran, B Choudhary - Ovarian Cancer-Updates in Tumour …, 2021 - intechopen.com
Ovarian cancer is the deadliest gynecological cancer among women with an overall 5-year
survival rate below 50% due to its asymptomatic nature, diagnosis at advanced stages, and …
survival rate below 50% due to its asymptomatic nature, diagnosis at advanced stages, and …